World’s Largest Pharmaceutical Company To Pay Almost $500M To Resolve False Claims Act Allegations

Pfizer Inc., the owner of Wyeth Pharmaceuticals Inc., will pay $491 million to resolve allegations of off-label marketing of the drug Rapamune.

Mark Campbell, the whistleblower and a former Wyeth sales representative, alleged that Wyeth illegally marketed, for over a decade, the transplant drug for uses that had not been approved by the U.S. Food & Drug Administration (“FDA”), including potentially dangerous uses subject to a “black box” warning, the most serious type of warning required by the FDA.

For more information, please see:
http://legalnewsline.com/issues/big-pharma/243255-wyeth-to-pay-491-million-to-resolve-multi-state-federal-off-label-marketing-lawsuit